4
Changes in Ownership
Evolent Health, Inc. Filed Acc 0001232583-17-000002
CEO, Valence Health sold 6,000 shares at $20.11 ($120,660)
- CEO, Valence Health acquired 6,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
WIGGINTON STEVE · CEO, Valence Health
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-03-01 | Exercise or conversion : show line 1 in the form | +6,000 | $3.84 | $23,040 | 365,692 | D |
| 2017-03-01 | Sale : show line 2 in the form | −6,000 | $20.11 | $120,660 | 359,692 | D |
| Open-market sales · 6,000 sh · avg $20.11 · $120,660 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2017-03-01 | Exercise or conversion : show line 3 in the form Class A Common Stock Option (right to buy) | −6,000 | $3.84 | 2024-04-01 | 6,000 | 429,680 | D |
Loading xslF345X03/primary_doc.xml…